Cantor Fitzgerald Reiterates Overweight on Eli Lilly and Co, Maintains $815 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Louise Chen reiterates an Overweight rating on Eli Lilly and Co (LLY) with a maintained price target of $815.
April 15, 2024 | 6:31 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald reaffirms an Overweight rating on Eli Lilly and maintains a $815 price target.
The reaffirmation of an Overweight rating and a high price target by a reputable analyst like Louise Chen from Cantor Fitzgerald could positively influence investor sentiment towards Eli Lilly, potentially driving up its stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100